13F filer · CIK 1571076
Aisling Capital LLC
New York, NY · filing since Q4 2013 · last filing Nov 13, 2019
Reported value
$45.3M
$-15.1M vs prior
Positions
5
New / sold out
1 / 0
Added / reduced
0 / 2
Turnover
0.0%
buys $0 · sells $16.0M
Top-10 weight
100.0%
Biggest buys vs Q2 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | VIEWRAY INC. | +18,964 | – | $0 |
Biggest sells vs Q2 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | AIMMUNE THERAPEUTICS INC. | -750,000 | -37.7% | $-15.7M |
| Reduced | CIDARA THERAPEUTICS INC. | -129,534 | -12.7% | $-258.5K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2019
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AIMMUNE THERAPEUTICS INC.COM | 1,240,000 | $26.0M | 57.34% |
| 2 | ADMA BIOLOGICS INCCOM | 3,608,171 | $16.1M | 35.46% |
| 3 | CIDARA THERAPEUTICS INC.COM | 891,614 | $1.8M | 3.93% |
| 4 | TRANSENTERIX INC.COM NEW | 2,389,352 | $1.5M | 3.27% |
| 5 | VIEWRAY INC.COM | 18,964 | $0 | 0.00% |